Literature DB >> 11922894

Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts.

Carmen P Lydell1, Andy Chan, Richard B Wambolt, Nandakumar Sambandam, Hannah Parsons, Gregory P Bondy, Brian Rodrigues, Kirill M Popov, Robert A Harris, Roger W Brownsey, Michael F Allard.   

Abstract

OBJECTIVE: Coupling of glucose oxidation to glycolysis is lower in hypertrophied than in non-hypertrophied hearts, contributing to the compromised mechanical performance of hypertrophied hearts. Here, we describe studies to test the hypothesis that low coupling of glucose oxidation to glycolysis in hypertrophied hearts is due to reduced activity and/or expression of the pyruvate dehydrogenase complex (PDC).
METHODS: We examined the effects of dichloroacetate (DCA), an inhibitor of PDC kinase, and of alterations in exogenous palmitate supply on coupling of glucose oxidation to glycolysis in isolated working hypertrophied and control hearts from aortic-constricted and sham-operated male Sprague-Dawley rats. It was anticipated that the addition of DCA or the absence of palmitate would promote PDC activation and consequently normalize coupling between glycolysis and glucose oxidation in hypertrophied hearts if our hypothesis was correct.
RESULTS: Addition of DCA or removal of palmitate improved coupling of glucose oxidation to glycolysis in control and hypertrophied hearts. However, coupling remained substantially lower in hypertrophied hearts. PDC activity in extracts of hypertrophied hearts was similar to or higher than in extracts of control hearts under all perfusion conditions. No differences were observed between hypertrophied and control hearts with respect to expression of PDC, PDC kinase, or PDC phosphatase.
CONCLUSIONS: Low coupling of glucose oxidation to glycolysis in hypertrophied hearts is not due to a reduction in PDC activity or subunit expression indicating that other mechanism(s) are responsible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922894      PMCID: PMC2131743          DOI: 10.1016/s0008-6363(01)00560-0

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  54 in total

Review 1.  Molecular biology and biochemistry of pyruvate dehydrogenase complexes.

Authors:  M S Patel; T E Roche
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

2.  Effects of moderate hypertension on cardiac function and metabolism in the rabbit.

Authors:  H Taegtmeyer; M L Overturf
Journal:  Hypertension       Date:  1988-05       Impact factor: 10.190

3.  Effects of mechanical activity and hormones on myocardial glucose and fatty acid utilization.

Authors:  J R Neely; M Whitmer; S Mochizuki
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

Review 4.  Fuel selection in animals.

Authors:  P J Randle
Journal:  Biochem Soc Trans       Date:  1986-10       Impact factor: 5.407

5.  Glutamic dehydrogenase from rat heart mitochondria. I. Purification and physical properties including molecular weight determination.

Authors:  H G McDaniel; M Yeh; R Jenkins; A Razzaque
Journal:  J Mol Cell Cardiol       Date:  1984-04       Impact factor: 5.000

6.  Radioisotopic assays of CoASH and carnitine and their acetylated forms in human skeletal muscle.

Authors:  G Cederblad; J I Carlin; D Constantin-Teodosiu; P Harper; E Hultman
Journal:  Anal Biochem       Date:  1990-03       Impact factor: 3.365

7.  A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue.

Authors:  D Constantin-Teodosiu; G Cederblad; E Hultman
Journal:  Anal Biochem       Date:  1991-11-01       Impact factor: 3.365

8.  Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts.

Authors:  Z el Alaoui-Talibi; S Landormy; A Loireau; J Moravec
Journal:  Am J Physiol       Date:  1992-04

9.  An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.

Authors:  G D Lopaschuk; R B Wambolt; R L Barr
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

10.  Myocardial oxygen consumption and the left ventricular pressure-volume area in normal and hypertrophic canine hearts.

Authors:  G Izzi; M R Zile; W H Gaasch
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

View more
  23 in total

1.  Innate short-circuiting of mitochondrial metabolism in cardiac hypertrophy: identification of novel consequences of enhanced anaplerosis.

Authors:  Michael N Sack
Journal:  Circ Res       Date:  2009-03-27       Impact factor: 17.367

Review 2.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

3.  Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.

Authors:  Stuart Rich; Jennifer Pogoriler; Aliya N Husain; Peter T Toth; Mardi Gomberg-Maitland; Stephen L Archer
Journal:  Chest       Date:  2010-11       Impact factor: 9.410

4.  Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons.

Authors:  Nader D Halim; Thomas Mcfate; Ahmed Mohyeldin; Peter Okagaki; Lioubov G Korotchkina; Mulchand S Patel; Nam Ho Jeoung; Robert A Harris; Michael J Schell; Ajay Verma
Journal:  Glia       Date:  2010-08       Impact factor: 7.452

5.  Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I.

Authors:  Andrew N Carley; Domenico M Taglieri; Jian Bi; R John Solaro; E Douglas Lewandowski
Journal:  Circ Heart Fail       Date:  2014-11-25       Impact factor: 8.790

6.  Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.

Authors:  Kayla M Pound; Natalia Sorokina; Kalpana Ballal; Deborah A Berkich; Mathew Fasano; Kathryn F Lanoue; Heinrich Taegtmeyer; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

7.  The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.

Authors:  Lin Piao; Yong-Hu Fang; Virgilio J J Cadete; Christian Wietholt; Dalia Urboniene; Peter T Toth; Glenn Marsboom; Hannah J Zhang; Idith Haber; Jalees Rehman; Gary D Lopaschuk; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2009-12-01       Impact factor: 4.599

Review 8.  Alterations in mitochondrial function in cardiac hypertrophy and heart failure.

Authors:  Moritz Osterholt; T Dung Nguyen; Michael Schwarzer; Torsten Doenst
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

9.  Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation.

Authors:  Ramzi J Khairallah; Maya Khairallah; Roselle Gélinas; Bertrand Bouchard; Martin E Young; Bruce G Allen; Gary D Lopaschuk; Christian F Deschepper; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2008-05-27       Impact factor: 5.000

10.  Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy.

Authors:  Marie A Schroeder; Helen J Atherton; Daniel R Ball; Mark A Cole; Lisa C Heather; Julian L Griffin; Kieran Clarke; George K Radda; Damian J Tyler
Journal:  FASEB J       Date:  2009-03-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.